CSF tau protein: A new prognostic marker for Guillain-Barré syndrome

K. Jin, A. Takeda, Y. Shiga, S. Sato, A. Ohnuma, H. Nomura, H. Arai, S. Kusunoki, M. Ikeda, Y. Itoyama

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)


We measured the CSF tau protein levels in 26 patients with Guillain-Barré syndrome. The levels of the poor outcome group (Hughes grade at 6 months was between II and VI, n = 6) were higher than those of the good outcome group (0 or I, n = 20) (p < 0.0005). The higher levels of CSF tau may reflect axonal degeneration and could predict a poor clinical outcome in Guillain-Barré syndrome.

Original languageEnglish
Pages (from-to)1470-1472
Number of pages3
Issue number8
Publication statusPublished - 2006 Oct
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'CSF tau protein: A new prognostic marker for Guillain-Barré syndrome'. Together they form a unique fingerprint.

Cite this